FELODIPINE\METOPROLOL: 46 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
46
Total FAERS Reports
9 (19.6%)
Deaths Reported
39
Hospitalizations
46
As Primary/Secondary Suspect
2
Life-Threatening
2
Disabilities
Active Ingredient: FELODIPINE\METOPROLOL SUCCINATE ·
First Report: 1999 · Latest Report: 20250524
What Are the Most Common FELODIPINE\METOPROLOL Side Effects?
#1 Most Reported
Vomiting
10 reports (21.7%)
#2 Most Reported
Hypotension
9 reports (19.6%)
#3 Most Reported
Hyperlactacidaemia
9 reports (19.6%)
All FELODIPINE\METOPROLOL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Vomiting | 10 | 21.7% | 0 | 9 |
| Acute kidney injury | 9 | 19.6% | 0 | 9 |
| Acute respiratory failure | 9 | 19.6% | 8 | 9 |
| Disorientation | 9 | 19.6% | 0 | 9 |
| Dyspnoea | 9 | 19.6% | 8 | 9 |
| Hyperlactacidaemia | 9 | 19.6% | 0 | 9 |
| Hypotension | 9 | 19.6% | 0 | 9 |
| Eczema | 8 | 17.4% | 0 | 8 |
| Eosinophilia | 8 | 17.4% | 0 | 8 |
Who Reports FELODIPINE\METOPROLOL Side Effects? Age & Gender Data
Gender: 66.7% female, 33.3% male. Average age: 66.2 years. Most reports from: FR. View detailed demographics →
Is FELODIPINE\METOPROLOL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 8 | 0 | 8 |
| 2018 | 9 | 0 | 9 |
| 2019 | 5 | 0 | 1 |
| 2020 | 9 | 8 | 9 |
| 2021 | 4 | 0 | 3 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
| 2025 | 1 | 0 | 0 |
What Is FELODIPINE\METOPROLOL Used For?
| Indication | Reports |
|---|---|
| Hypertension | 20 |
| Product used for unknown indication | 15 |
| Poisoning deliberate | 5 |
Official FDA Label for FELODIPINE\METOPROLOL
Official prescribing information from the FDA-approved drug label.